{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T06:51:18Z","timestamp":1772779878195,"version":"3.50.1"},"reference-count":63,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2016,6,10]],"date-time":"2016-06-10T00:00:00Z","timestamp":1465516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01-CA129544"],"award-info":[{"award-number":["R01-CA129544"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01-CA172820"],"award-info":[{"award-number":["R01-CA172820"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0157125","type":"journal-article","created":{"date-parts":[[2016,6,10]],"date-time":"2016-06-10T21:00:55Z","timestamp":1465592455000},"page":"e0157125","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in Mice"],"prefix":"10.1371","volume":"11","author":[{"given":"Kavindra","family":"Nath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary E.","family":"Putt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis B.","family":"Leeper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley","family":"Garman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine L.","family":"Nathanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry D.","family":"Glickson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,6,10]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3322\/canjclin.56.2.106","article-title":"Cancer statistics, 2006","volume":"56","author":"A Jemal","year":"2006","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"ref2","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1002011","article-title":"Inhibition of mutated, activated BRAF in metastatic melanoma","volume":"363","author":"KT Flaherty","year":"2010","journal-title":"N Engl J Med"},{"issue":"9","key":"ref3","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/iub.1193","article-title":"Targeting RAS\/RAF\/MEK\/ERK signaling in metastatic melanoma","volume":"65","author":"AX Wang","year":"2013","journal-title":"IUBMB Life"},{"key":"ref4","article-title":"Genomic correlates of response to CTLA4 blockade in metastatic melanoma","author":"EM Van Allen","year":"2015","journal-title":"Science"},{"issue":"3","key":"ref5","first-page":"30","article-title":"Checkpoint inhibitors in the treatment of cutaneous malignant melanoma","volume":"3","author":"J Lutzky","year":"2014","journal-title":"Chin Clin Oncol"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/01.cji.0000190168.53793.6b","article-title":"Comparison of common gamma-chain cytokines, interleukin-2, interleukin-7, and interleukin-15 for the in vitro generation of human tumor-reactive T lymphocytes for adoptive cell transfer therapy","volume":"29","author":"S Liu","year":"2006","journal-title":"J Immunother"},{"issue":"5796","key":"ref7","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1126\/science.1129003","article-title":"Cancer regression in patients after transfer of genetically engineered lymphocytes","volume":"314","author":"RA Morgan","year":"2006","journal-title":"Science"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1152\/physrev.00044.2003","article-title":"Melanin pigmentation in mammalian skin and its hormonal regulation","volume":"84","author":"A Slominski","year":"2004","journal-title":"Physiol Rev"},{"issue":"10","key":"ref9","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.humpath.2013.02.022","article-title":"Melanogenesis affects overall and disease-free survival in patients with stage III and IV melanoma","volume":"44","author":"AA Brozyna","year":"2013","journal-title":"Hum Pathol"},{"key":"ref10","article-title":"Melanin content in melanoma metastases affects the outcome of radiotherapy","author":"AYAA Bro","year":"2016","journal-title":"Oncotarget"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/ijc.23664","article-title":"Inhibition of melanogenesis as a radiation sensitizer for melanoma therapy","volume":"123","author":"AA Brozyna","year":"2008","journal-title":"Int J Cancer"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1002\/ijc.24005","article-title":"Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells","volume":"124","author":"A Slominski","year":"2009","journal-title":"Int J Cancer"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/nbm.3240","article-title":"Lonidamine induces intracellular tumor acidification and ATP depletion in breast, prostate and ovarian cancer xenografts and potentiates response to doxorubicin","volume":"28","author":"K Nath","year":"2015","journal-title":"NMR Biomed"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/nbm.3260","article-title":"Effects of hyperglycemia on lonidamine-induced acidification and de-energization of human melanoma xenografts and sensitization to melphalan","volume":"28","author":"K Nath","year":"2015","journal-title":"NMR Biomed"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/nbm.2824","article-title":"<sup>31<\/sup>P and <sup>1<\/sup>H MRS of DB-1 melanoma xenografts: lonidamine selectively decreases tumor intracellular pH and energy status and sensitizes tumors to melphalan","volume":"26","author":"K Nath","year":"2013","journal-title":"NMR Biomed"},{"key":"ref16","article-title":"The metabolism of tumors","author":"Warburg","year":"1930"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrc2255","article-title":"A microenvironmental model of carcinogenesis","volume":"8","author":"RA Gatenby","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"ref18","first-page":"1194","article-title":"Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer","volume":"56","author":"LE Gerweck","year":"1996","journal-title":"Cancer Res"},{"issue":"16","key":"ref19","first-page":"4373","article-title":"Acid pH in tumors and its potential for therapeutic exploitation","volume":"49","author":"IF Tannock","year":"1989","journal-title":"Cancer Res"},{"issue":"6","key":"ref20","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1158\/0008-5472.CAN-08-2394","article-title":"The potential role of systemic buffers in reducing intratumoral extracellular pH and acid-mediated invasion","volume":"69","author":"AS Silva","year":"2009","journal-title":"Cancer Res"},{"issue":"7","key":"ref21","first-page":"1219","article-title":"Tumor acidity, ion trapping and chemotherapeutics. II. pH-dependent partition coefficients predict importance of ion trapping on pharmacokinetics of weakly basic chemotherapeutic agents","volume":"66","author":"N Raghunand","year":"2003","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0006-2952(98)00306-2","article-title":"Plasmalemmal pH-gradients in drug-sensitive and drug-resistant MCF-7 human breast carcinoma xenografts measured by <sup>31<\/sup>P magnetic resonance spectroscopy","volume":"57","author":"N Raghunand","year":"1999","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"ref23","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/sj.bjc.6690455","article-title":"Enhancement of chemotherapy by manipulation of tumour pH","volume":"80","author":"N Raghunand","year":"1999","journal-title":"Br J Cancer"},{"issue":"6","key":"ref24","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1158\/0008-5472.CAN-07-5575","article-title":"Bicarbonate increases tumor pH and inhibits spontaneous metastases","volume":"69","author":"IF Robey","year":"2009","journal-title":"Cancer Res"},{"issue":"9","key":"ref25","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0006-2952(99)00022-2","article-title":"pH and drug resistance. I. Functional expression of plasmalemmal V-type H<sup>+<\/sup>-ATPase in drug-resistant human breast carcinoma cell lines","volume":"57","author":"R Martinez-Zaguilan","year":"1999","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"ref26","first-page":"2965","article-title":"Hydrogen ion-mediated enhancement of cytotoxicity of bis-chloroethylating drugs in rat mammary carcinoma cells in vitro","volume":"49","author":"E Jahde","year":"1989","journal-title":"Cancer Res"},{"issue":"6","key":"ref27","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/BF00685157","article-title":"Nigericin enhances mafosfamide cytotoxicity at low extracellular pH","volume":"27","author":"E Jahde","year":"1991","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0959-8049(93)90587-6","article-title":"Metabolic response of AH13r rat tumours to cyclophosphamide as monitored by pO<sub>2<\/sub> and pH semi-microelectrodes","volume":"29A","author":"E Jahde","year":"1992","journal-title":"Eur J Cancer"},{"issue":"18","key":"ref29","first-page":"4937","article-title":"Growth and metastasis of fresh human melanoma tissue in mice with severe combined immunodeficiency","volume":"51","author":"KR Hill LL","year":"1991","journal-title":"Cancer Res"},{"issue":"23","key":"ref30","first-page":"6840","article-title":"Flow cytometric determination of the frequency and heterogeneity of expression of human melanoma-associated antigens","volume":"49","author":"D Berd","year":"1989","journal-title":"Cancer Res"},{"issue":"14","key":"ref31","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"H Li","year":"2009","journal-title":"Bioinformatics"},{"issue":"5","key":"ref32","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ng.806","article-title":"A framework for variation discovery and genotyping using next-generation DNA sequencing data","volume":"43","author":"MA DePristo","year":"2011","journal-title":"Nat Genet"},{"issue":"9","key":"ref33","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"A McKenna","year":"2010","journal-title":"Genome Res"},{"issue":"10","key":"ref34","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1038\/nprot.2015.105","article-title":"Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR","volume":"10","author":"H Yang","year":"2010","journal-title":"Nat Protoc"},{"issue":"6","key":"ref35","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1093\/nar\/gku1363","article-title":"CODEX: a normalization and copy number variation detection method for whole exome sequencing","volume":"43","author":"Y Jiang","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3109\/09553000903419304","article-title":"Three endpoints of in vivo tumour radiobiology and their statistical estimation","volume":"86","author":"E Demidenko","year":"2010","journal-title":"Int J Radiat Biol"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1214\/ss\/1177013815","article-title":"Bootstrap method for standard errors, confidence intervals, and other measures of statistical accuracy","volume":"1","author":"B Efron","year":"1986","journal-title":"Stat Sci"},{"issue":"7","key":"ref38","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S1076-6332(03)80681-5","article-title":"Enhancement of hyperglycemia-induced acidification of human melanoma xenografts with inhibitors of respiration and ion transport","volume":"8","author":"R Zhou","year":"2001","journal-title":"Acad Radiol"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ijc.2910540126","article-title":"Potentiation of DNA-adduct formation and cytotoxicity of platinum-containing drugs by low pH","volume":"54","author":"A Atema","year":"1993","journal-title":"Int J Cancer"},{"issue":"5\u20136","key":"ref40","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/sj.bjc.6690127","article-title":"Potentiation of anti-cancer drug activity at low intratumoral pH induced by the mitochondrial inhibitor m-iodobenzylguanidine (MIBG) and its analogue benzylguanidine (BG)","volume":"79","author":"A Kuin","year":"1999","journal-title":"Br J Cancer"},{"issue":"1","key":"ref41","first-page":"219","article-title":"The cytotoxicity of melphalan and its relationship to pH, hypoxia and drug uptake","volume":"15","author":"LD Skarsgard","year":"1995","journal-title":"Anticancer Res"},{"issue":"9","key":"ref42","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1158\/1078-0432.CCR-04-2472","article-title":"Reduction of intracellular pH as a strategy to enhance the pH-dependent cytotoxic effects of melphalan for human breast cancer cells","volume":"11","author":"P Wong","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"2","key":"ref43","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/bjc.1998.34","article-title":"Multidrug resistance protein-mediated transport of chlorambucil and melphalan conjugated to glutathione","volume":"77","author":"K Barnouin","year":"1998","journal-title":"Br J Cancer"},{"issue":"1","key":"ref44","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1158\/1078-0432.CCR-07-1061","article-title":"Bendamustine (Treanda) displays a distinct pattern of cytotoxicity and unique mechanistic features compared with other alkylating agents","volume":"14","author":"LM Leoni","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"13","key":"ref45","first-page":"2814","article-title":"Mechanism of action of the antineoplastic drug lonidamine: <sup>31<\/sup>P and <sup>13<\/sup>C nuclear magnetic resonance studies","volume":"55","author":"H Ben-Horin","year":"1995","journal-title":"Cancer Res"},{"issue":"2","key":"ref46","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1023\/A:1005819604858","article-title":"Mechanism of action of lonidamine in the 9L brain tumor model involves inhibition of lactate efflux and intracellular acidification","volume":"36","author":"O Ben-Yoseph","year":"1998","journal-title":"J Neurooncol"},{"issue":"18","key":"ref47","first-page":"5179","article-title":"Noninvasive real-time monitoring of intracellular cancer cell metabolism and response to lonidamine treatment using diffusion weighted proton magnetic resonance spectroscopy","volume":"60","author":"Y Mardor","year":"2000","journal-title":"Cancer Res"},{"issue":"8","key":"ref48","first-page":"617","article-title":"Regulation of intracellular pH in human melanoma: Potential therapeutic implications","volume":"1","author":"ML Wahl","year":"2002","journal-title":"Molecular Cancer Therapeutics"},{"issue":"Pt 2","key":"ref49","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1042\/bj3430281","article-title":"The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation","volume":"343","author":"AP Halestrap","year":"1999","journal-title":"Biochem J"},{"key":"ref50","article-title":"Inhibition of mitochondrial complex II by the anti-cancer agent lonidamine","author":"L Guo","year":"2015","journal-title":"J Biol Chem"},{"key":"ref51","article-title":"The anti-tumour agent lonidamine is a potent inhibitor of the mitochondrial pyruvate carrier and plasma membrane monocarboxylate transporters","author":"B Nancolas","year":"2016","journal-title":"Biochem J"},{"issue":"3","key":"ref52","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ccr.2013.02.003","article-title":"Oncogenic BRAF regulates oxidative metabolism via PGC1alpha and MITF","volume":"23","author":"R Haq","year":"2013","journal-title":"Cancer Cell"},{"issue":"4","key":"ref53","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1158\/2159-8290.CD-13-0440","article-title":"Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis","volume":"4","author":"TJ Parmenter","year":"2014","journal-title":"Cancer Discov"},{"issue":"10","key":"ref54","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1074\/jbc.M115.701862","article-title":"Bonded Cumomer Analysis of Human Melanoma Metabolism Monitored by <sup>13<\/sup>C NMR Spectroscopy of Perfused Tumor Cells","volume":"291","author":"AA Shestov","year":"2016","journal-title":"J Biol Chem"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/978-1-4614-4989-8_37","article-title":"Metabolic network analysis of DB1 melanoma cells: how much energy is derived from aerobic glycolysis?","volume":"765","author":"AA Shestov","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3389\/fonc.2016.00135","article-title":"<sup>13<\/sup>C MRS and LC-MS Flux Analysis of Tumor Intermediary Metabolism","volume":"6","author":"AA Shestov","year":"2016","journal-title":"Front Oncol"},{"issue":"8","key":"ref57","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"FS Hodi","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"ref58","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/CJI.0b013e31823735d6","article-title":"Ipilimumab in treatment-naive and previously treated patients with metastatic melanoma: retrospective analysis of efficacy and safety data from a phase II trial","volume":"35","author":"JA Thompson","year":"2012","journal-title":"J Immunother"},{"issue":"7","key":"ref59","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrc3760","article-title":"Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond","volume":"14","author":"M Holderfield","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"7494","key":"ref60","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature13121","article-title":"Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma","volume":"508","author":"C Sun","year":"2014","journal-title":"Nature"},{"issue":"26","key":"ref61","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"PB Chapman","year":"2011","journal-title":"N Engl J Med"},{"issue":"8","key":"ref62","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1056\/NEJMoa1112302","article-title":"Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib","volume":"366","author":"JA Sosman","year":"2012","journal-title":"N Engl J Med"},{"issue":"3","key":"ref63","doi-asserted-by":"crossref","first-page":"e1089381","DOI":"10.1080\/2162402X.2015.1089381","article-title":"Co-inhibition of colony stimulating factor-1 receptor and BRAF oncogene in mouse models of BRAF melanoma","volume":"5","author":"SF Ngiow","year":"2015","journal-title":"Oncoimmunology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0157125","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T11:39:34Z","timestamp":1589024374000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0157125"}},"subtitle":[],"editor":[{"given":"Andrzej T","family":"Slominski","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,6,10]]},"references-count":63,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0157125","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,10]]}}}